FDA Submissions, Approvals And Other Actions: March 2001.

              FDA Submissions, Approvals And Other Actions:                                March 2001 Company [*]        Product       Description (Symbol) CANCER Atrix              Leuprogel     Leuprolide acetate Laboratories                     for subcutaneous depot Inc. (ATRX)                      for Injection: leuprolide is                                  a lutelnizing hormone-                                  releasing hormone agonist AVAX               M-Vax and     Autologous cancer Technologies       O-Vax         vaccines Inc. (AVXT) Corixa Corp.       Bexxar        Radioimmunotherapy (CRXA)                           antibody conjugated to                                  iodine-131 Ligand             Targretin     Capsules; bexarotene; Pharmaceuticals                  synthetic retinold analogue Inc. (LGND)                      that selectively activates                                  retinold X receptors Lorus              GTI-2501      Antlsense compound Therapeutics Inc. (Canada; LORFF; TSE:LOR) Matrix             IntraDose     Clsplatin/epinephrine Pharmaceuticals    Injectable Inc. (MATX)        Gel MediGene Inc.      G207          Anticancer therapeutic; (unit of MediGene                modified herpes simplex AG; Germany;                     virus genetically engineered Neuer Markt:MDG)                 to replicate in and kill cancer                                  cells while sparing normal                                  cells Neoprobe Corp.     Radiolabeled  Agent is designed to assist (OTC BB:NEOP)      agent         In the diagnosis and surg-                                  ical management of breast                                  cancer patients …